Sam68 is a druggable vulnerability point in cancer stem cells

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Sam68 (Src associated in mitosis of 68 kDa) is a multifunctional protein involved in RNA processing and signaling.
• Recent studies identify Sam68 as a target for drugs inhibiting Wnt/β-catenin transcription.
• These drugs selectively eliminate cancer stem cell (CSC) activity by engaging Sam68.

Purpose of the Study:

• To discuss the role of Sam68 in tumorigenesis and cancer stem cell maintenance.
• To review Sam68's involvement in chromatin regulation essential for CSCs.
• To explore advances in CSC-targeting drug discovery focused on Sam68.

Main Methods:

• Literature review of Sam68's functions in cancer.
• Analysis of Sam68's role in chromatin regulation within CSCs.
• Review of drug discovery efforts targeting Sam68.

Main Results:

• Sam68 plays a significant role in maintaining neoplastic self-renewal and tumor-initiating functions.
• Sam68 is implicated in chromatin regulation processes vital for CSCs.
• Modulating Sam68's cellular distribution and interactions is a key therapeutic strategy.

Conclusions:

• Sam68 is a critical vulnerability in cancer stem cells.
• Targeting Sam68 presents a promising therapeutic avenue to inhibit neoplastic stemness in human tumors.
• Further research into Sam68-targeted therapies could lead to novel cancer treatments.